Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3267
+0.01223.88%
Volume:1.02M
Turnover:331.13K
Market Cap:23.23M
PE:-0.95
High:0.3303
Open:0.3300
Low:0.3150
Close:0.3145
Loading ...
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 05, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans